Key Record Dates
ClinicalTrials.gov Identifier: | NCT05288166 |
---|---|
Brief Title: | A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) (CYCLONE 3) |
First Submitted : | March 10, 2022 |
First Submitted that Met QC Criteria : | March 18, 2022 |
First Posted : | March 21, 2022 |
Last Update Submitted that Met QC Criteria : | May 23, 2023 |
Last Update Posted : | May 24, 2023 |